Clinical Trial Update: A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing insulin degludec/liraglutide fixed-ratio combination with insulin degludec alone and liraglutide alone in Chinese adults with type 2 dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Degludec/Liraglutide
• insulin degludec (insulin degludec)
• liraglutide (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2020-07-07